ASX Share rice
Fri 14 Aug 2020 - 06:26:pm (Sydney)

RHY Share Price

RHYTHM BIOSCIENCES LIMITEDRHYHealth Care Equipment & Services

RHY Company Information

Name:

Rhythm Biosciences Limited

Sector:

Healthcare

Industry:

Diagnostics & Research

Address:

480 Collins Street Melbourne Australia 3000

Phone:

61 3 9614 0600

CEO & COO:

Mr. Glenn Gilbert

Technical Director, Chair of the Clinical Advisory Board & Director:

Dr. Trevor John Lockett Ph.D.

Company Sec.:

Mr. Adrien Michele Wing C.P.A., B.Bus, B.Acc, CPA

Joint Company Sec.:

Ms. Pauline Moffatt

Company Overview:

Rhythm Biosciences Limited, a medical diagnostics technology company, engages in developing and commercializing medical diagnostics technology in Australia and internationally. It is developing ColoSTAT, a test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Melbourne, Australia.

RHY Share Price Information

Shares Issued:

176.31M

Market Capitalisation:

$19.39M

Revenue (TTM):

$743.82K

Revenue Per Share (TTM):

$0.01

Earnings per Share:

$-0.025

Operating Margin (TTM):

$-4.13

Return On Assets (TTM):

$-0.33

Return On Equity (TTM):

$-0.55

Quarterly Revenue Growth (YOY):

-0.942

Gross Profit(TTM):

$1.03M

Diluted Earnings Per Share (TTM):

$-0.03

RHY CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-110,262

Change To Liabilities:

$164.12K

Total Cashflow From Investing Activities:

$-110,262

Net Income:

$-2,546,159

Total Cash From Operating Activities:

$-2,941,596

Depreciation:

$65.37K

Change To Account Receivables:

$-762,465

Capital Expenditures:

$110.26K

RHY Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-2,546,159

Net Income:

$-2,546,159

Gross Profit:

$1.03M

Operating Income:

$-3,714,843

Total Revenue:

$1.03M

Total Operating Expenses:

$3.71M

RHY Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$533.96K

Total Liabilities:

$379.71K

Total Stockholder Equity:

$5.85M

Total Assets:

$6.23M

Common Stock:

$10.04M

Retained Earnings:

$-4,371,766

Other Liabilities:

$6.72K

Cash:

$4.73M

Total Current Liabilities:

$373K

Property - Plant & Equipment:

$90.17K

Net Tangible Assets:

$5.32M

Total Current Assets:

$5.61M

Net Receivables:

$797.70K

Short-Term Investments:

$624.12K

Accounts Payable:

$207.16K

Non Currrent Assets (Other):

$624.12K

Short-Term Investments:

$624.12

Non Current Liabilities Total:

$6.72K

RHY Share Price History

RHY News

16 Apr, 2020
Rhythm Biosciences Limited (ASX:RHY) shareholders will doubtless be very grateful to see the share price up 58% in the...
17 Jan, 2020
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
15 Oct, 2019
It hasn't been the best quarter for Rhythm Biosciences Limited (ASX:RHY) shareholders, since the share price has...